Welcome Wondros Family and
Friends! We are beta testing and need
your help improving this product.
Share Feedback
Locations
1 locations
Status
Completed
Study Type
Interventional
Timeframe
Days 1-10
Accepts healthy volunteers
No
Age
18 Years - 80 Years
Gender
All
Placebo Arm
Yes
Locations
72 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Week 24
Accepts healthy volunteers
No
Age
18 Years - 80 Years
Gender
All
Placebo Arm
No
Locations
5 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Up to 8 Weeks
Accepts healthy volunteers
No
Age
18 Years - 99 Years
Gender
All
Placebo Arm
No
Locations
34 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Baseline Day 1 to Week 26
Accepts healthy volunteers
No
Age
18 Years - 65 Years
Gender
All
Placebo Arm
Yes
Locations
13 locations
Status
Completed
Study Type
Interventional
Timeframe
25±2 days
Accepts healthy volunteers
No
Age
45 Years +
Gender
All
Placebo Arm
Yes
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
Immediately after the surgery up to 30 days. If the hospital stay exceeds 30 days, major adverse events that occur prior to discharge from hospital will be included.
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Enrolling by invitation
Study Type
Interventional
Timeframe
Baseline to 3 months
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Baseline, 6 months
Accepts healthy volunteers
No
Age
18 Years - 75 Years
Gender
Male
Placebo Arm
No
Locations
14 locations
Status
Recruiting
Study Type
Interventional
Timeframe
Immediately post-embolization procedure
Accepts healthy volunteers
No
Age
22 Years +
Gender
All
Placebo Arm
No
Locations
2 locations
Status
Recruiting
Study Type
Interventional
Timeframe
through study completion, on average 15-months
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
2 months post-baseline
Accepts healthy volunteers
No
Age
60 Years - 89 Years
Gender
All
Placebo Arm
Yes
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
At day 30
Accepts healthy volunteers
No
Age
Birth - 25 Years
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Completed
Study Type
Interventional
Timeframe
Screening to Day 28
Accepts healthy volunteers
No
Age
18 Years - 55 Years
Gender
All
Placebo Arm
Yes
Locations
2 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
Up to approximately 4 weeks
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
Assessed on Day 1,7 and 30
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients
This study will evaluate the efficacy of oral Foipan® (camostat mesilate) compared with the current standard of care in reducing the duration of vi...
Sponsored by:
Stanford University
Trial Location:
Stanford University, Stanford, California 94305, United States
Estimated trial timing:
December 19, 2020 - May 15, 2021
Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in A...
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risank...
Sponsored by:
AbbVie
Trial Location:
Advanced Gastroenterology, P.C /ID# 224396, Chandler, Arizona 85224-1636, United States
Estimated trial timing:
September 30, 2020 - February 11, 2028
Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL
The primary objective of this phase 1b study is to evaluate the safety and tolerability of blinatumomab and AMG 404 in combination in adults with R...
Sponsored by:
Amgen
Trial Location:
Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
Estimated trial timing:
October 02, 2020 - January 23, 2023
Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic M...
This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety and efficacy of miricorilant (CORT118335) in obese patient...
Sponsored by:
Corcept Therapeutics
Trial Location:
Site #143, Bentonville, Arkansas 72712, United States
Estimated trial timing:
September 09, 2020 - October 01, 2022
Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients
Annovis is conducting a clinical study to investigate Posiphen in patients with Early Alzheimer's Disease (AD) and Early Parkinson's Disease (PD). ...
Sponsored by:
Annovis Bio Inc.
Trial Location:
Hawaii Pacific Neuroscience, Honolulu, Hawaii 96817, United States
Estimated trial timing:
August 14, 2020 - January 31, 2022
Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies
The primary objective of this single arm, prospective feasibility study, Impact of Frailty on Clinical Outcomes of Patients Treated for Thoracoabdo...
Sponsored by:
University of Southern California
Trial Location:
Keck Hospital of University of Southern California, Los Angeles, California 90033, United States
Estimated trial timing:
February 23, 2021 - May 01, 2028
Tailored Non-Pharmacotherapy Services for Chronic Pain: Testing Scalable and Pragmatic Approaches
The RESOLVE study is a multicenter comparative effectiveness trial of cognitive-behavioral therapy for chronic pain (CBT-CP) delivered via two tele...
Sponsored by:
Kaiser Permanente
Trial Location:
Kaiser Permanente Washington Health Research Institute, Seattle, Washington 98101, United States
Estimated trial timing:
January 14, 2021 - August 31, 2024
Testopel ® vs. Generic Testosterone Pellets.
The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Co...
Sponsored by:
University of Miami
Trial Location:
University of Miami, Department of Urology, Miami, Florida 33136, United States
Estimated trial timing:
March 12, 2020 - December 12, 2022
Instylla HES Hypervascular Tumor Pivotal Study
To determine whether Instylla HES has the ability to effectively embolize targeted arterial segments of hypervascular tumors as well as (i.e., is n...
Sponsored by:
Instylla, Inc.
Trial Location:
Boston Medical Center, Boston, Massachusetts 02118, United States
Estimated trial timing:
January 04, 2021 - September 30, 2023
MISSION-CJ for Justice-Involved Homeless Veterans
The purpose of this study is to determine whether Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking - Crim...
Sponsored by:
VA Office of Research and Development
Trial Location:
VA Bedford HealthCare System, Bedford, MA, Bedford, Massachusetts 01730, United States
Estimated trial timing:
July 01, 2021 - February 28, 2025
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
A recently completed study suggested that processing speed and attention (PS/A) oriented cognitive training (VSOP) produced robust effect on PS/A a...
Sponsored by:
University of Rochester
Trial Location:
Feng Lin, Rochester, New York 14642-0001, United States
Estimated trial timing:
August 18, 2020 - May 31, 2025
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
This phase I trial investigates the side effects and effectiveness of chemotherapy followed by a donor (allogeneic) stem cell transplant when given...
Sponsored by:
M.D. Anderson Cancer Center
Trial Location:
M D Anderson Cancer Center, Houston, Texas 77030, United States
Estimated trial timing:
January 14, 2021 - May 09, 2025
First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects
Primary Objective: To assess the safety and tolerability of SAR441255 after ascending single subcutaneous (SC) doses Secondary Objectives: To as...
Sponsored by:
Sanofi
Trial Location:
Investigational site number 8400001, Knoxville, Tennessee 37920, United States
Estimated trial timing:
April 25, 2019 - September 26, 2019
A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)
The purpose of this study is to evaluate the safety, tolerability, and efficacy in participants with advanced/metastatic or recurrent malignancies ...
Sponsored by:
Merck Sharp & Dohme LLC
Trial Location:
Istituto Europeo di Oncologia IRCCS-Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative (, Milano, 20141, Italy
Estimated trial timing:
October 28, 2020 - June 28, 2024
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
Assessing the efficacy and safety of DEXTENZA, sustained release dexamethasone 0.4 mg insert following corneal transplant surgery (PKP, DSEK, DMEK)...
Sponsored by:
Nicole Fram M.D.
Trial Location:
Advanced Vision Care, Los Angeles, California 90067, United States
Estimated trial timing:
October 16, 2020 - June 01, 2023
Our website uses cookies, as almost all websites do, to help provide you with the best experience we can. You can learn more about all the cookies and the information we collect by reading our Privacy Policy.
